Eucrates Biomedical Acquisition Corp. Quarterly Liabilities and Equity in USD from Q3 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Eucrates Biomedical Acquisition Corp. quarterly Liabilities and Equity history and growth rate from Q3 2020 to Q4 2022.
  • Eucrates Biomedical Acquisition Corp. Liabilities and Equity for the quarter ending December 31, 2022 was $12.5M, a 88.1% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $12.5M -$92.6M -88.1% Dec 31, 2022 10-K 2023-04-13
Q3 2022 $106M +$193K +0.18% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $105M -$385K -0.37% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $105M -$526K -0.5% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $105M -$720K -0.68% Dec 31, 2021 10-K 2023-04-13
Q3 2021 $105M +$105M +40528% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $106M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $106M Mar 31, 2021 10-Q 2021-07-16
Q4 2020 $106M Dec 31, 2020 10-K 2022-04-11
Q3 2020 $259K Sep 30, 2020 10-Q 2020-12-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.